← Back to headlines
Plus Therapeutics Reports Q2 Earnings Miss
Plus Therapeutics announced GAAP EPS of -$1.31, missing analyst estimates by $0.45, while reaffirming its full-year financial outlook.
17 Aug, 04:59 — 17 Aug, 04:59
Sources
Showing 1 of 1 sources
